MedTrace Logo

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

NCT05819619 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2025-11-17

Study results available
· View outcomes & findings →

Summary

Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.

Conditions

Interventions

DRUG

Prophylactic use of ibuprofen and ondansetron post misoprostol administration

Prophylactic use of ibuprofen and ondansetron post misoprostol administration

DRUG

Use of ibuprofen and ondansetron at symptom onset post misoprostol administration

Administration of ibuprofen or ondansetron only when experiencing pain or nausea respectively post misoprostol administration.

Sponsors & Collaborators

  • Hackensack Meridian Health

    lead OTHER

Principal Investigators

  • Melissa Figueroa, MD · Hackensack Meridian Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-20
Primary Completion
2024-04-01
Completion
2024-04-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05819619 on ClinicalTrials.gov